The chart above plots the price of RYTM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 13 sessions over that window: $111 on 30 June 2026 through $107 on 17 July 2026.
Market cap$7.4B
52-week range$75.84 – $118
Avg volume260.7K
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026
RYTM insider trades
SEC Form 4 · last 90 days · newest reported trade 14 Sep 2026
Open-market buys0
Open-market sells6
Net sold$28.80M
Non-trade filings5
DateInsiderTypeSharesValue
14 Sep 2026Meeker David PPresident and CEOSell50,000$5.13M
31 Aug 2026Smith Hunter CChief Financial OfficerSell62,774$6.62M
13 Aug 2026Lee Jennifer KaydenEVP, Head of North AmericaSell75,834$8.90M
13 Aug 2026Garfield AlastairChief Scientific OfficerSell7,763$913K
13 Aug 2026Shulman JosephChief Technical OfficerSell5,079$608K
12 Aug 2026Mazabraud YannEVP, Head of InternationalSell57,000$6.62M
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
14 Sep 2026Meeker David PPresident and CEOOption exercise50,000$303K
31 Aug 2026Smith Hunter CChief Financial OfficerOption exercise57,187$1.47M
13 Aug 2026Lee Jennifer KaydenEVP, Head of North AmericaOption exercise56,601$997K
13 Aug 2026Shulman JosephChief Technical OfficerOption exercise2,024$14K
12 Aug 2026Mazabraud YannEVP, Head of InternationalOption exercise46,625$317K
RYTM reported financials
SEC EDGAR XBRL
RYTM reported revenue of $189.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$196.5M.
FigureReportedPeriod
Revenue
$189.8M
31 Dec 2025 fiscal year
Net income
−$196.5M
31 Dec 2025 fiscal year
Diluted EPS
−$3.11
31 Dec 2025 fiscal year
Total assets
$437.3M
30 Jun 2026 at period end
Total equity
$103.0M
30 Jun 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
RYTM earnings
SEC EDGAR
DatePeriodEPSRevenue
30 Jun 2026Q2 2026$-0.73—
31 Mar 2026Q1 2026$-0.83—
31 Dec 2025FY 2025$-3.11—
30 Sep 2025Q3 2025$-0.82—
30 Jun 2025Q2 2025$-0.75—
31 Mar 2025Q1 2025$-0.81—
31 Dec 2024FY 2024$-4.34—
30 Sep 2024Q3 2024$-0.73—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
12 of the 45 institutional funds we track reported a RYTM position for the quarter ended 30 Jun 2026 — a combined $892.4M; the latest of those filings landed 02 Sep 2026.